Icalziss

Calcium chloride dihydrate, the active ingredient in Icalziss, is a calcium salt presented as an unspecified strength and form for extracorporeal use. It helps restore extracellular calcium levels in patients with hypocalcemia, supports cardiac stability during hyperkalemic emergencies, and provides essential calcium during dialysis or massive transfusion procedures in clinical settings.

GNH USA supplies Icalziss as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Icalziss is used as an electrolyte replenisher to correct calcium deficits in several clinical situations. - Hypocalcemia: restores serum calcium concentrations to normal levels. - Hyperkalemic cardiac arrest: stabilizes myocardial cell membranes and reduces arrhythmic risk. - Massive transfusion protocols: supplies calcium ions lost during citrate anticoagulation of blood products. - Renal replacement therapy: corrects calcium balance during dialysis procedures.

Calcium chloride dihydrate may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Infusion site irritation or pain - Transient hypotension or flushing - Nausea or vomiting - Metallic taste in the mouth - Headache or dizziness

Serious or Rare Side Effects: - Hypercalcemia leading to cardiac arrhythmias - Severe hypotension or cardiovascular collapse - Tissue necrosis at extravasation sites - Anaphylactic or severe allergic reactions - Cardiac arrest in the setting of rapid administration

When using Icalziss, clinicians should observe several safety measures to minimize risks. - Monitor serum calcium: check levels before and during therapy. - Assess cardiac function: continuous ECG monitoring is recommended. - Use caution in renal impairment: adjust dose as needed. - Avoid rapid infusion: administer over the recommended time to prevent hypotension. - Review concomitant digoxin therapy: calcium may increase digoxin toxicity. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Calcium chloride dihydrate can interact with several medicines; awareness of major and moderate interactions helps ensure safe use.

Major Interactions (Avoid): - Digoxin: increased risk of arrhythmias. - Calcium channel blockers: enhanced hypotensive effect. - Loop diuretics: altered calcium excretion may cause imbalance. - Bicarbonate solutions: precipitation of calcium carbonate. - Blood products containing citrate: excess calcium may cause hypercalcemia.

Moderate Interactions (Monitor Closely): - ACE inhibitors: possible additive blood pressure effects. - Beta‑blockers: monitor for bradycardia. - Antacids containing aluminum or magnesium: may affect calcium absorption. - Phosphate binders: potential calcium‑phosphate precipitation. - Magnesium supplements: monitor combined electrolyte levels.